News

Perspectum Announces Executive Leadership Changes

Perspectum and Avant Santéannounce strategic partnership to strengthen quantitative imaging for metabolic and liver research in Mexico and Latin America

Perspectum and InHealth announce national diagnostics partnership to boost Oxford CDC capacity and widen access to advanced MRI across the UK

New analysis shows corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States

UK Biobank Completes World’s Largest Human Imaging Study

Marea Therapeutics Publishes Phase 2 Trial Results in The Lancet

Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes

New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease

Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development